Research Peptides in Baton Rouge, LA

Shipping research peptides to Baton Rouge

Every Baton Rouge order ships from Peptides Factory Direct as a stable lyophilized powder, packed for safe domestic transit to Baton Rouge and the wider Louisiana research community. Lots are third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC, and a Certificate of Analysis is available on request to support Baton Rouge research records.

Research peptide categories shipped to Baton Rouge

Baton Rouge researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides Baton Rouge researchers request most

These are among the most-studied compounds shipped to Baton Rouge and the surrounding Louisiana research community. Every profile is grounded in the research literature and provided strictly for laboratory context; nothing here is a human-use claim.

DSIP (Delta Sleep-Inducing Peptide) research

DSIP (delta sleep-inducing peptide) is a naturally occurring neuropeptide studied for its reported association with delta-wave sleep and stress regulation. The research literature is mixed, which makes it an active area of investigation.

Research mechanism. DSIP research examines its role in sleep architecture, stress-hormone modulation, and pain endpoints, though the exact mechanism remains a research question.

Sleep research. Studied for sleep-quality and delta-wave endpoints in models.

Stress-regulation research. Examined for stress-hormone modulation.

Pain-modulation research. Used in exploratory pain-endpoint designs.

How it compares. DSIP is studied specifically for sleep and stress endpoints, distinct from the hormone and cognitive peptides.

Research pairings. Generally studied as a standalone sleep-research peptide.

Reference research values. Research references commonly cite 100-300 mcg before rest periods, used as-needed. Reference values only.

Full DSIP research profile → · Specialty peptides

Selank (anxiolytic nootropic) research

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia. It is studied for anxiolytic (anti-anxiety) and cognitive endpoints without the sedation associated with classic anxiolytics.

Research mechanism. Selank research focuses on modulation of GABAergic and monoamine signaling and on brain-derived neurotrophic factor (BDNF) expression, with interest in anxiety and focus endpoints.

Anxiolytic research. Studied for anxiety endpoints without sedation in models.

Cognitive / focus research. Examined for attention and mental-clarity variables.

Neuroprotection and immune research. Its tuftsin lineage links it to immune-signaling studies.

How it compares. Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research.

Research pairings. Selank + Semax is a common cognitive-research pairing (anxiety plus focus endpoints).

Reference research values. Research references commonly cite 250-500 mcg daily across 2-4 week cycles. Reference values only.

Full Selank research profile → · Cognitive & Neurological peptides

Hexarelin (potent GHRP) research

Hexarelin is a synthetic hexapeptide and one of the most potent growth-hormone-releasing peptides studied in research, with reported activity beyond GH release including cardiovascular-tissue signaling.

Research mechanism. Hexarelin strongly activates the GH-secretagogue receptor. Research notes desensitization with continuous exposure and increases in prolactin and cortisol, so cycled study designs are common.

Potent GH-release research. Studied where maximal GH-pulse stimulation is the variable.

Cardiac-tissue research. Examined for reported GH-independent cardiovascular signaling.

Cycled GHRP designs. Used in research that models receptor desensitization.

How it compares. Hexarelin is the most potent GHRP studied here but with the most off-target signaling and desensitization, contrasting with the gentler Ipamorelin.

Research pairings. Hexarelin is studied in cycled designs and monitored for prolactin/cortisol; it is rarely combined continuously with other GHRPs.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily across 4-8 week cycles. Reference values only.

Full Hexarelin research profile → · Growth Hormone & Muscle peptides

HCG (Human Chorionic Gonadotropin) research

HCG (human chorionic gonadotropin) is a glycoprotein hormone that mimics luteinizing hormone. It has a well-established research profile and is studied for its downstream effects on gonadal hormone production.

Research mechanism. HCG research focuses on LH-receptor activation, stimulating gonadal tissue in research models - the downstream counterpart to upstream GnRH and Kisspeptin signaling.

Reproductive-hormone research. Studied for gonadal-hormone and fertility endpoints.

LH-analog research. A model compound for LH-receptor studies.

Hormone-axis research. Examined in models of endogenous hormone support.

How it compares. HCG mimics LH downstream, while Gonadorelin and Kisspeptin act upstream in the same axis.

Research pairings. Studied alongside GnRH peptides in hormone-axis research designs. Banned by WADA - relevant for sports-science researchers.

Reference research values. Research references commonly cite 250-500 IU two to three times weekly. Reference values only.

Full HCG research profile → · Specialty peptides

Melanotan I (Afamelanotide) research

Melanotan I (afamelanotide) is a linear analog of alpha-MSH that is more selective than Melanotan II, studied for melanogenesis endpoints with fewer of the off-target effects reported for MT-II.

Research mechanism. Melanotan I research focuses on MC1R-mediated melanin synthesis, the pathway central to pigmentation research, with a more selective profile than the non-selective MT-II.

Pigmentation research. Studied for melanogenesis endpoints with a selective profile.

Photoprotection research. Examined in models of UV response.

Melanocortin-receptor research. A more selective MC1R model compound.

How it compares. Melanotan I is more selective and reportedly better tolerated in models than Melanotan II, with a narrower pigmentation focus.

Research pairings. Generally studied as a standalone selective melanocortin agonist.

Reference research values. Research references commonly cite a loading figure of 0.5-1 mg daily followed by 2-3 times weekly maintenance. Reference values only.

Full Melanotan I research profile → · Sexual Health & Tanning peptides

GHRP-2 (Growth Hormone Releasing Peptide-2) research

GHRP-2 is a synthetic hexapeptide growth-hormone secretagogue, studied as a middle ground between GHRP-6 (strong appetite signaling) and Ipamorelin (selective and clean).

Research mechanism. GHRP-2 activates the GH-secretagogue receptor for GH release, with a reportedly smaller appetite response than GHRP-6 and somewhat more than Ipamorelin in research models.

GH-release research. A potent GHRP for growth-hormone-pulse studies.

Body-composition models. Studied for downstream metabolic endpoints.

GHRH synergy research. Paired with CJC-1295 in stacking studies.

How it compares. GHRP-2 is studied as a balance between GHRP-6 potency/appetite and Ipamorelin selectivity.

Research pairings. GHRP-2 + CJC-1295 is a common research pairing; prolactin is monitored in models.

Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.

Full GHRP-2 research profile → · Growth Hormone & Muscle peptides

PT-141 (Bremelanotide) research

PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. It is studied for sexual-function endpoints through a central-nervous-system mechanism rather than a vascular one.

Research mechanism. PT-141 research focuses on activation of melanocortin receptors (notably MC4R) in the central nervous system, which is the distinguishing feature versus vascular mechanisms studied for other compounds.

Libido / sexual-function research. Studied for arousal endpoints in both male and female models via CNS signaling.

Melanocortin-pathway research. A model compound for MC4R signaling studies.

Centrally-mediated research. Used where a central rather than vascular mechanism is the variable.

How it compares. Unlike vascular-pathway compounds, PT-141 acts centrally; unlike Melanotan I/II it is studied primarily for sexual-function rather than tanning endpoints.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 1-2 mg administered 45-90 minutes before the modeled endpoint, used as-needed rather than daily. Reference values only.

Full PT-141 research profile → · Sexual Health & Tanning peptides

Tirzepatide (dual GLP-1/GIP agonist) research

Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is one of the most-studied modern metabolic research peptides because it engages two incretin pathways at once.

Research mechanism. Tirzepatide research examines combined GLP-1 and GIP signaling on insulin response, satiety, and energy handling, with the dual-pathway mechanism the central research distinction.

Weight-management research. Studied for body-weight endpoints via dual incretin signaling.

Glucose-metabolism research. Examined for combined GLP-1/GIP metabolic effects.

Comparative incretin studies. Frequently compared with semaglutide.

How it compares. Tirzepatide adds GIP activity on top of GLP-1, which is the defining contrast with single-pathway semaglutide in research.

Research pairings. Studied as a standalone dual-agonist model or compared with semaglutide.

Reference research values. Research references describe a titration model from 2.5 mg up to 15 mg weekly over several weeks. Reference values only.

Full Tirzepatide research profile → · Fat Loss & Weight Management peptides

Semaglutide (GLP-1 agonist) research

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a long half-life. It is among the most-studied metabolic research peptides because of the extensive GLP-1 literature on glucose handling and satiety signaling.

Research mechanism. Semaglutide research centers on GLP-1-receptor activation: enhanced glucose-dependent insulin signaling, slowed gastric emptying, and central satiety pathways. These endpoints are studied in metabolic and weight-related research models.

Weight-management research. The dominant research theme is appetite and body-weight modeling via GLP-1 signaling.

Glucose-metabolism research. Studied for glucose-dependent insulin and metabolic endpoints.

Comparative GLP-1 studies. Frequently compared with Tirzepatide in dual-pathway research.

How it compares. Semaglutide is a single-pathway GLP-1 agonist; Tirzepatide is a dual GLP-1/GIP agonist. The two are the central comparison in modern metabolic-peptide research.

Research pairings. In research it is studied as a standalone GLP-1 model or compared head-to-head with Tirzepatide.

Reference research values. Research references describe a titration model from 0.25 mg up to 2.4 mg weekly over several weeks. Reference values only.

Full Semaglutide research profile → · Fat Loss & Weight Management peptides

Ovagen (Organ Bioregulator) research

Ovagen is a peptide bioregulator from the Khavinson family, studied for reproductive and organ tissue-support concepts in research models. Peptide bioregulators are investigated for tissue-specific normalization of gene expression and protein synthesis.

Research mechanism. Ovagen research centers on tissue-specific peptide bioregulation - the concept that short peptides can support normal function and protein synthesis in their target organ tissue - within reproductive and organ-support research models.

Reproductive-tissue research. Studied for reproductive and organ tissue-support endpoints in models.

Organ-support research. Examined in bioregulator research focused on tissue normalization concepts.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator research framework.

How it compares. Ovagen is an organ/reproductive-tissue bioregulator, distinct from the vascular bioregulator Vesugen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Vesugen, Pinealon) in organ-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Ovagen research profile → · Specialty peptides

Dihexa (high-potency nootropic) research

Dihexa is a synthetic peptide derived from angiotensin IV, studied for its reported high potency in promoting synaptic connections (synaptogenesis). The literature describes it as extremely potent relative to BDNF in model systems, with limited human data.

Research mechanism. Dihexa research focuses on the hepatocyte-growth-factor / c-Met system and synaptogenesis, with interest in memory and cognition endpoints.

Synaptogenesis research. Studied for formation of new synaptic connections in models.

Memory and cognition research. Examined for learning and memory endpoints.

Neurodegeneration models. Used in exploratory neurodegeneration research.

How it compares. Dihexa is studied as far more potent than Semax/Selank in model systems but with much less data, making it a specialized research tool.

Research pairings. Generally studied as a standalone high-potency nootropic.

Reference research values. Research references commonly cite 5-10 mg daily in 4-8 week cycled windows. Reference values only - an advanced compound with limited data; use caution.

Full Dihexa research profile → · Cognitive & Neurological peptides

Vesugen (KED Vascular Bioregulator) research

Vesugen is a short vascular peptide bioregulator (a tripeptide, KED) from the Khavinson family, studied for endothelial and vessel-wall support signaling in research models. It is the vascular-tissue member of the short-peptide bioregulator group.

Research mechanism. Vesugen research focuses on vascular and endothelial tissue bioregulation - the concept that a tissue-specific short peptide can support normal endothelial function and vessel-wall protein synthesis - within cardiovascular-tissue research models.

Vascular / endothelial research. Studied for endothelial-function and vessel-support endpoints in models.

Cardiovascular-tissue research. Examined in bioregulator research focused on vascular tissue normalization.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator framework.

How it compares. Vesugen is the vascular/endothelial bioregulator, distinct from the organ bioregulator Ovagen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Ovagen, Pinealon) in tissue-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Vesugen research profile → · Specialty peptides

BPC-157 (Body Protection Compound 157) research

BPC-157 (Body Protection Compound 157) is a synthetic, stable pentadecapeptide of 15 amino acids derived from a partial sequence of a protein found in human gastric juice. In the research literature it is one of the most frequently studied "body protection" peptides because of its stability in gastric and aqueous environments and its broad activity across connective and epithelial tissue models.

Research mechanism. Research models associate BPC-157 with up-regulation of growth-factor signaling (notably the VEGFR2 pathway and FAK-paxillin signaling) that supports angiogenesis - the formation of new blood vessels - in injured tissue. It is also studied for modulation of the nitric-oxide system and for interaction with the gut-brain axis. These mechanisms are the subject of ongoing pre-clinical investigation and are reported in animal and in-vitro studies, not approved clinical indications.

Tendon and ligament repair research. A large share of BPC-157 literature examines tendon-to-bone healing, ligament models, and the tensile recovery of connective tissue after controlled injury. Researchers study it both locally (near a modeled injury site) and systemically because of its reported stability.

Gastrointestinal models. Because the parent sequence originates in gastric juice, BPC-157 is heavily studied in models of gut-lining integrity, ulceration, and inflammatory bowel conditions, where angiogenesis and epithelial repair are the variables of interest.

Inflammation and joint research. Anti-inflammatory signaling and joint-tissue models are a third common research theme, frequently paired with TB-500 in comparative stacking studies.

How it compares. Compared with TB-500, BPC-157 is studied as a faster-acting, more localized repair peptide; compared with GHK-Cu it targets connective and gut tissue rather than skin and hair. It is one of the most stability-tested peptides in the research catalog.

Research pairings. In the literature BPC-157 is most often studied alongside TB-500 (Thymosin Beta-4) for connective-tissue work, since the two are reported to act through complementary repair pathways - BPC-157 more locally and TB-500 through deeper, slower regeneration.

Reference research values. Research-reference protocols in the literature commonly cite 250-500 mcg once or twice daily over a 4-12 week study window, with some maintenance models at 250 mcg daily. These figures are reference values from published research only and are not dosing instructions for any living subject.

Full BPC-157 research profile → · Healing & Recovery peptides

Pinealon (EDR Tripeptide) research

Pinealon is a short synthetic peptide bioregulator (a tripeptide) from the Khavinson family of peptide bioregulators. It is studied for neuroprotective, pineal/circadian, and cognitive-support concepts in research models, where short peptides are investigated for tissue-specific gene-regulatory activity.

Research mechanism. Pinealon research centers on peptide bioregulation in neural tissue - the idea that short peptides can influence gene expression and protein synthesis in a tissue-specific way - alongside antioxidant and neuroprotective signaling and pineal/circadian-axis variables.

Cognitive research. Studied for learning, memory, and cognitive-function endpoints in models.

Neuroprotection research. Examined for protection of neural tissue against oxidative and ischemic stress in study models.

Circadian / pineal research. Investigated for pineal-axis and sleep-regulation variables.

How it compares. Pinealon is neuro/cognitive-focused, distinguishing it from telomere-focused Epithalon and the organ-support bioregulators Ovagen and Vesugen.

Research pairings. Studied alongside other Khavinson bioregulators such as Epithalon in longevity-oriented research designs.

Reference research values. Research references commonly cite 1-3 mg daily in short cognitive/longevity-oriented study cycles. Reference values only - not for human or animal use.

Full Pinealon research profile → · Cognitive & Neurological peptides

Research applications studied in Baton Rouge

• Sleep research (DSIP). Studied for sleep-quality and delta-wave endpoints in models.
• Anxiolytic research (Selank). Studied for anxiety endpoints without sedation in models.
• Potent GH-release research (Hexarelin). Studied where maximal GH-pulse stimulation is the variable.
• Reproductive-hormone research (HCG). Studied for gonadal-hormone and fertility endpoints.
• Pigmentation research (Melanotan I). Studied for melanogenesis endpoints with a selective profile.

How Baton Rouge researchers order and store material

Ordering for a Baton Rouge lab is done in the Peptides Factory Direct portal, with one-time or recurring options and a checkout confirmation of laboratory research use. Material ships to Baton Rouge as a lyophilized powder for refrigerated storage; after reconstitution keep it cold and use within the standard research window. Baton Rouge researchers remain responsible for compliance with applicable law, and nothing supplied is for human or animal consumption. Open the order portal.

Why Baton Rouge researchers choose Peptides Factory Direct

What sets Peptides Factory Direct apart for Baton Rouge researchers is documentation, not claims. Each Baton Rouge order is third-party tested to a 99%+ purity target, ships with lot tracking and a COA on request, and arrives quickly by domestic carrier. The same catalog, purity standard, and research-use terms apply whether material ships to Baton Rouge or anywhere else in the US.

Nearby Louisiana research areas we ship to

Frequently asked questions

All Louisiana cities · All states · Research guides

External references: Louisiana (Wikipedia) · U.S. Census Bureau